Cargando…

ABO incompatible renal transplant: Transfusion medicine perspective

INTRODUCTION: Our study presents an analysis of the trends of ABO antibody titers and the TPE (Therapeutic Plasma Exchange) procedures required pre and post ABO incompatible renal transplant. MATERIALS AND METHODS: Twenty nine patients underwent ABO incompatible renal transplant during the study per...

Descripción completa

Detalles Bibliográficos
Autores principales: Makroo, Raj Nath, Nayak, Sweta, Chowdhry, Mohit, Jasuja, Sanjiv, Sagar, Gaurav, Rosamma, N. L., Thakur, Uday Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345280/
https://www.ncbi.nlm.nih.gov/pubmed/28316440
http://dx.doi.org/10.4103/0973-6247.200767
_version_ 1782513684944257024
author Makroo, Raj Nath
Nayak, Sweta
Chowdhry, Mohit
Jasuja, Sanjiv
Sagar, Gaurav
Rosamma, N. L.
Thakur, Uday Kumar
author_facet Makroo, Raj Nath
Nayak, Sweta
Chowdhry, Mohit
Jasuja, Sanjiv
Sagar, Gaurav
Rosamma, N. L.
Thakur, Uday Kumar
author_sort Makroo, Raj Nath
collection PubMed
description INTRODUCTION: Our study presents an analysis of the trends of ABO antibody titers and the TPE (Therapeutic Plasma Exchange) procedures required pre and post ABO incompatible renal transplant. MATERIALS AND METHODS: Twenty nine patients underwent ABO incompatible renal transplant during the study period. The ABO antibody titers were done using the tube technique and titer reported was the dilution at which 1+ reaction was observed. The baseline titers of anti-A and anti-B antibodies were determined. The titer targeted was ≤8. Patients were subjected to 1 plasma volume exchange with 5% albumin and 2 units of AB group FFP (Fresh Frozen Plasma) in each sitting. TPE procedures post-transplant were decided on the basis of rising antibody titer with/ without graft dysfunction. RESULTS: The average number of TPE procedures required was 4-5 procedures/patient in the pretransplant and 2-3/patient in the post-transplant period. An average titer reduction of 1 serial dilution/procedure was noted for Anti-A and 1.1/procedure for Anti-B. Number of procedures required to reach the target titer was not significantly different for Anti-A and Anti-B (P = 0.98). Outcome of the transplant did not differ significantly by reducing titers to a level less than 8 (P = 0.32). The difference in the Anti-A and Anti-B titers at 14th day post-transplant was found to be clinically significant (P = 0.042). CONCLUSION: With an average of 4-5 TPE procedures pretransplant and 2-3 TPE procedures post transplants, ABO incompatible renal transplantations can be successfully accomplished.
format Online
Article
Text
id pubmed-5345280
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-53452802017-03-17 ABO incompatible renal transplant: Transfusion medicine perspective Makroo, Raj Nath Nayak, Sweta Chowdhry, Mohit Jasuja, Sanjiv Sagar, Gaurav Rosamma, N. L. Thakur, Uday Kumar Asian J Transfus Sci Original Article INTRODUCTION: Our study presents an analysis of the trends of ABO antibody titers and the TPE (Therapeutic Plasma Exchange) procedures required pre and post ABO incompatible renal transplant. MATERIALS AND METHODS: Twenty nine patients underwent ABO incompatible renal transplant during the study period. The ABO antibody titers were done using the tube technique and titer reported was the dilution at which 1+ reaction was observed. The baseline titers of anti-A and anti-B antibodies were determined. The titer targeted was ≤8. Patients were subjected to 1 plasma volume exchange with 5% albumin and 2 units of AB group FFP (Fresh Frozen Plasma) in each sitting. TPE procedures post-transplant were decided on the basis of rising antibody titer with/ without graft dysfunction. RESULTS: The average number of TPE procedures required was 4-5 procedures/patient in the pretransplant and 2-3/patient in the post-transplant period. An average titer reduction of 1 serial dilution/procedure was noted for Anti-A and 1.1/procedure for Anti-B. Number of procedures required to reach the target titer was not significantly different for Anti-A and Anti-B (P = 0.98). Outcome of the transplant did not differ significantly by reducing titers to a level less than 8 (P = 0.32). The difference in the Anti-A and Anti-B titers at 14th day post-transplant was found to be clinically significant (P = 0.042). CONCLUSION: With an average of 4-5 TPE procedures pretransplant and 2-3 TPE procedures post transplants, ABO incompatible renal transplantations can be successfully accomplished. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5345280/ /pubmed/28316440 http://dx.doi.org/10.4103/0973-6247.200767 Text en Copyright: © 2017 Asian Journal of Transfusion Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Makroo, Raj Nath
Nayak, Sweta
Chowdhry, Mohit
Jasuja, Sanjiv
Sagar, Gaurav
Rosamma, N. L.
Thakur, Uday Kumar
ABO incompatible renal transplant: Transfusion medicine perspective
title ABO incompatible renal transplant: Transfusion medicine perspective
title_full ABO incompatible renal transplant: Transfusion medicine perspective
title_fullStr ABO incompatible renal transplant: Transfusion medicine perspective
title_full_unstemmed ABO incompatible renal transplant: Transfusion medicine perspective
title_short ABO incompatible renal transplant: Transfusion medicine perspective
title_sort abo incompatible renal transplant: transfusion medicine perspective
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345280/
https://www.ncbi.nlm.nih.gov/pubmed/28316440
http://dx.doi.org/10.4103/0973-6247.200767
work_keys_str_mv AT makroorajnath aboincompatiblerenaltransplanttransfusionmedicineperspective
AT nayaksweta aboincompatiblerenaltransplanttransfusionmedicineperspective
AT chowdhrymohit aboincompatiblerenaltransplanttransfusionmedicineperspective
AT jasujasanjiv aboincompatiblerenaltransplanttransfusionmedicineperspective
AT sagargaurav aboincompatiblerenaltransplanttransfusionmedicineperspective
AT rosammanl aboincompatiblerenaltransplanttransfusionmedicineperspective
AT thakurudaykumar aboincompatiblerenaltransplanttransfusionmedicineperspective